The coronavirus vaccines have generally been shown to be safe in clinical trials, but some people will inevitably have allergic reactions to the contents of the vaccines from Moderna (NASDAQ: MRNA) and other companies. In this video from Motley Fool Live, recorded on Jan. 25, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss why investors shouldn’t be worried about the small number of events that were bound to happen.
Coronavirus Vaccine Allergic Reactions: Red Flag or Par for the Course?
Latest from Blog
Alcoa (NYSE: AA) stock moved higher in Wednesday morning trading — up 6.2% as of 10:15…
The White House provided an upbeat vaccine forecast on Tuesday night, pushing airline stocks higher on…
Churchill Capital IV (NYSE: CCIV) stock dropped 12% Wednesday, and still traded almost 11% below Tuesday’s…
Shares of Veritiv (NYSE: VRTV) spiked 80% higher on Wednesday morning and traded up more than…
The S&P 500 ended in the red today, down more than 1.2%, but one of the…